DNB Fund-Nordic Equities Retail A (N) (EUR)

Reference Data

ISIN LU2233193197
Valor Number
Bloomberg Global ID
Fund Name DNB Fund-Nordic Equities Retail A (N) (EUR)
Fund Provider DNB Asset Management AS Stockholm, Sweden
Phone: +46 8 473 41 00
Web: www.cim.se
Fund Provider DNB Asset Management AS
Representative in Switzerland FundPartner Solutions (Suisse) SA
Genève 75
Distributor(s) Fund Channel (Suisse) SA
Nyon 2
Phone: +4122 0000 VZ VermögensZentrum AG
Zürich
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The sub-fund seeks to invest mainly in equities in Denmark, Finland, Norway and Sweden, with the aim to achieve a positive relative return over the long-term.
Peculiarities

Fund Prices

Current Price * 109.18 EUR 01.08.2025
Previous Price * 111.29 EUR 31.07.2025
52 Week High * 122.40 EUR 26.09.2024
52 Week Low * 94.32 EUR 09.04.2025
NAV * 109.18 EUR 01.08.2025
Issue Price * 109.18 EUR 01.08.2025
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 44,251,283
Unit/Share Assets *** 20,363
Trading Information SIX

Performance

YTD Performance -2.93% 31.12.2024
01.08.2025
YTD Performance (in CHF) -3.77% 31.12.2024
01.08.2025
1 month -1.01% 01.07.2025
01.08.2025
3 months -0.99% 02.05.2025
01.08.2025
6 months -4.54% 03.02.2025
01.08.2025
1 year -7.95% 01.08.2024
01.08.2025
2 years +10.79% 01.08.2023
01.08.2025
3 years +1.68% 01.08.2022
01.08.2025
5 years +7.44% 12.10.2020
01.08.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Novo Nordisk AS Class B 7.12%
Nordea Bank Abp 5.52%
Atlas Copco AB Class A 5.26%
Nokia Oyj 4.48%
DSV AS 3.48%
Volvo AB Class B 3.30%
Hexagon AB Class B 3.16%
NKT AS 3.00%
AstraZeneca PLC 2.85%
Novonesis (Novozymes) B Class B 2.75%
Last data update 30.06.2025

Cost / Risk

TER *** 0.904%
TER date *** 30.06.2025
Performance Fee ***
PTR
Max. Management Fee *** 0.85%
Ongoing Charges *** 0.90%
SRRI ***
SRRI date *** 30.06.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)